Rong Ai
NHC Key Laboratory Of Hormones And Development
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Impaired mitochondrial degradation of CHCHD2 promotes metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma by upregulating VEGFA.
Journal: Oncogene
Published: November 01, 2024
The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: April 17, 2024
Identification and validation of plasma AGRN as a novel diagnostic biomarker of hepatitis B Virus-related chronic hepatitis and liver fibrosis/cirrhosis.
Journal: Histology and histopathology
Published: January 10, 2024
Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis.
Journal: Lipids in health and disease
Published: March 09, 2023
LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p.
Journal: Journal of hepatocellular carcinoma
Published: March 02, 2023
FOXO1-Induced miR-502-3p Suppresses Colorectal Cancer Cell Growth through Targeting CDK6.
Journal: Journal of oncology
Published: September 01, 2022
MiR-19a suppresses ferroptosis of colorectal cancer cells by targeting IREB2.
Journal: Bioengineered
Published: May 23, 2022
Identification of potential plasma markers for hepatitis B virus-related chronic hepatitis and liver fibrosis/cirrhosis.
Journal: Journal of medical virology
Published: January 13, 2022
Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology.
Journal: Journal of hepatocellular carcinoma
Published: January 07, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026